ArticleAnnals of translational medicine2025

Raltitrexed as a substitute for 5-fluorouracil in combination with pembrolizumab and platinum in a patient with metastatic esophageal squamous cell carcinoma and coronary artery disease: a case report.

Matthew Van Oirschot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.